Case Report: Successful Treatment With Monoclonal Antibodies in One APDS Patient With Prolonged SARS-CoV-2 Infection Not Responsive to Previous Lines of Treatment

We described the case of a patient affected by activated PI3K-kinase delta syndrome (APDS) and a long-lasting and pauci-symptomatic SARS-CoV-2 infection, treated with multiple therapeutic agents including remdesivir and SARS-CoV-2-neutralizing monoclonal antibodies. We detected the clearance of the...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Beatrice Rivalta, Donato Amodio, Carmela Giancotta, Veronica Santilli, Lucia Pacillo, Paola Zangari, Nicola Cotugno, Emma Concetta Manno, Andrea Finocchi, Stefania Bernardi, Luna Colagrossi, Leonarda Gentile, Cristina Russo, Carlo Federico Perno, Paolo Rossi, Caterina Cancrini, Paolo Palma
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	Frontiers Media S.A. 2022-06-01
Edice:	Frontiers in Immunology
Témata:	SARS-CoV-2 COVID19 IEI activated PI3K delta syndrome (APDS) monoclonal antibody remdesivir
On-line přístup:	https://www.frontiersin.org/articles/10.3389/fimmu.2022.891274/full
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!